Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,265 | 12,596 | 8,424 | 14,542 | 40,155 |
| Marketable Securities | 72,506 | 82,438 | 88,447 | 93,337 | 75,887 |
| Receivables | N/A | N/A | 7,000 | N/A | N/A |
| TOTAL | $88,597 | $97,742 | $104,560 | $108,803 | $118,758 |
| Non-Current Assets | |||||
| PPE Net | 10,978 | 11,322 | 12,095 | 12,628 | 12,865 |
| Intangibles | 33,937 | 33,966 | 34,347 | 34,390 | 34,434 |
| Other Non-Current Assets | 7,920 | 8,168 | 8,363 | 8,557 | 8,946 |
| TOTAL | $52,835 | $53,456 | $54,805 | $55,575 | $56,245 |
| Total Assets | $141,432 | $151,198 | $159,365 | $164,378 | $175,003 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,410 | 36,210 | 31,389 | 30,779 | 29,763 |
| Accrued Expenses | 2,868 | 3,410 | 3,585 | 3,017 | 4,852 |
| TOTAL | $40,839 | $41,959 | $38,737 | $37,556 | $36,613 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,209 | 1,428 | N/A | N/A | N/A |
| Deferred Revenues | 296 | 296 | 296 | 296 | 296 |
| Other Non-Current Liabilities | 4,994 | 5,260 | 5,517 | 5,768 | 6,013 |
| TOTAL | $6,203 | $6,688 | $5,517 | $5,768 | $6,013 |
| Total Liabilities | $47,042 | $48,647 | $44,254 | $43,324 | $42,626 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,961 | 3,952 | 3,941 | 3,391 | 3,348 |
| Common Shares | 990 | 961 | 845 | 848 | 836 |
| Retained earnings | -586,706 | -570,704 | -554,876 | -547,639 | -534,629 |
| Other shareholders' equity | 3 | -10 | 17 | 133 | 386 |
| TOTAL | $94,390 | $102,551 | $115,111 | $121,054 | $132,377 |
| Total Liabilities And Equity | $141,432 | $151,198 | $159,365 | $164,378 | $175,003 |